In pancreatic cancer, although CD44+ cells themselves were more tumorigenic than CD44− cells, CD44+/CD24+/ESA+ cells had more stem cell-like characteristics than CD44−/CD24−/ESA− cells. This evidence concerns the gene CD44 and familial pancreatic carcinoma.